It is known that the consumption of glucose (sugar) is much higher in tumours than in healthy tissues. Using this property of the tumour cells, Dr Rodrigues used a very sensitive modified magnetic resonance imaging (MRI) approach to produce images of the glucose consumption and metabolism of the tumour. The technique has been tested pre-clinically, and proved to be able to assess early response to cancer treatment. Clinical trials are at a preparatory stage. The lead author, Tiago Brandão Rodrigues, was supported by a 2-year Marie Skłodowska-Curie (MSCA) grant managed by the Research Executive Agency.